Antibody drugs are drugs prepared by antibody engineering technology based on cell engineering technology and gene engineering technology. They have the advantages of high specificity, uniform properties, and can be directed to specific targets. Their application prospects in the treatment of various diseases, especially in the field of tumor therapy, have attracted much attention. The research and development of monoclonal antibody, multi-clonal antibody and ADC were also unveiled at this forum.
Cell and Gene Therapy Forum
Different from small molecule and antibody drugs, cell and gene therapy has great application potential for many diseases that cannot find patent drug targets because it can directly act on genetic material. Since the 1990s, the related research in the field of cell and gene therapy has shown a continuous upward trend, and the research attention in this field has gradually increased. Today's forum discussed topics such as TCR-redirected immune cell therapy, advances in gene editing therapy in thalassemia, TCRT-T solid tumor destruction, immune cell therapy for solid tumors, and TIL cell therapy.